Drugs / H1 influenza antigen
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06125717 Comparator | Jul 2022 → Mar 2023 | influenza | Terrestrial Bio, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H1 influenza antigen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06125717 ↗ |
| Modality | Vaccine | “15 μg or 7.5 μg of an H1N1 influenza vaccine” PMID 38843267 ↗ Jun 2024 |